Research programme: flavivirus therapeutics - Pharmasset
Alternative Names: 2'-Deoxy-2'-fluorocytidine; FdCLatest Information Update: 29 Aug 2007
At a glance
- Originator Emory University; Pharmasset
- Class Nucleosides
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 29 Sep 2003 Preclinical trials in Hepatitis C treatment in USA (unspecified route)